2018 marked the 90th anniversary of UCB. Since our creation in 1928, UCB has been characterized by a strong entrepreneurial spirit, determination and resilience, long term views, and a strong belief science and innovation would improve humanity.

Today too many patients living with severe chronic diseases are still looking for solutions as they face daily challenges in their lives. We are convinced that our Patient Value Strategy will lead to a positive impact for patients, our stakeholders and UCB.

With the Patient Value Strategy, UCB aims to deliver unique outcomes and the best patient experience to as many lives as possible within specific populations. UCB wants to be present and lead in specific patient populations by 2025, defined by leading patient share in the relevant segment.

Therefore, our innovation will focus on differentiated medicines with high predictability of response, and leveraging new scientific platforms wherever appropriate. In an increasingly constrained external world where innovation is essential, we confirm our Patient Value Strategy to drive UCB’s future success and sustainable growth.

Learn more about the progress we made last year and our aspirations for the future in our 2018 Integrated Annual Report.